$FEED

Glibert Christian Michael sold $144K of FEED

Glibert Christian Michael sold 210,000 shares of ENvue Medical, Inc. (FEED) at $0.69 ($0.14M total) on 2026-06-22.

Original reporting
SEC EDGAR · Glibert Christian Michael
Published Jun 22, 2026, 5:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 5:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FEED
Neutral
medium confidence
Mentioned
$FEED
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FEEDNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 210,000 shares at $0.6880, after which the insider reports 0 shares held.

02

Market read

Traders may monitor FEED for any follow-through in volume/sentiment, but the filing alone does not change fundamentals.

03

What to watch

No 10b5-1 plan is stated, but the article also provides no context on prior holdings, compensation structure, or whether the sale was part of a broader planned liquidity event.

Relevance 4/10Novelty 4/10Timing: today’s SEC Form 4 disclosure (2026-06-22)

Background

The article is an SEC Form 4 insider transaction disclosure for ENvue Medical, Inc. (FEED).

Company-level read

Ticker impact

$FEEDNeutralMedium confidence
Context

SEC Form 4 shows insider Glibert Christian Michael sold 210,000 FEED shares at $0.6880 on 2026-06-22, leaving 0 shares.

Expected impact

Near-term impact likely minimal; any reaction would be more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is a same-day disclosed open-market sale with no 10b5-1 plan and results in zero remaining shares, but it lacks accompanying company-specific operational or guidance changes.

Market effects

No sector-level read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales can be non-informational (taxes, diversification, liquidity needs), especially when the filing provides no rationale.

Key entities

  • ENvue Medical, Inc.

    Company whose insider transaction is disclosed on SEC Form 4 (FEED).

  • Glibert Christian Michael

    Insider who sold 210,000 FEED shares on 2026-06-22.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).